MedicineNet Home > Allergy Nasal Drug for 2-Year-Olds
	Diseases & Conditions   |   Procedures & Tests   |   Medications   |   Dictionary

Allergy Nasal Drug for 2-Year-Olds

A short article.

For more, please visit the following MedicineNet.com areas:

• Allergy
• mometasone furoate (Nasonex)
• FocusOnAllergies.com, edited by Alan Szeftel, M.D., Asthma and Allergy Center in Santa Monica and Assistant Professor of Medicine at UCLA.
• FocusOnKidsHealth.com

Frederick Hecht, MD, FAAP, FACMG
Associate Chief Medical Editor, MedicineNet.com

FDA OKs inhaled allergy drug for 2-year-olds

Last Updated: 2002-07-19 13:02:46 -0400

NEW YORK (Reuters Health) - The US Food and Drug Administration (FDA) has approved the allergy drug Nasonex (mometasone furoate), made by Schering-Plough Corp., for use in children as young as 2 years old, the company reported Friday.

In December 1999, the agency cleared the drug for patients aged 3 years and older.

According to Schering-Plough, the approval makes Nasonex the only prescription nasal-inhaled corticosteroid approved for children that young. It was based on a study showing the drug's safety and tolerability in more than 50 children, the company said.

Schering-Plough estimated that allergic rhinitis, or nasal inflammation, affects more than 6 million children each year.

Copyright © 2002 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.